News
Special Report: The first patient has been dosed in Prescient Therapeutics Phase 2a clinical trial of PTX-100 in patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL). Prescient ...
Special Report: The first patient has been dosed in Prescient Therapeutics Phase 2a clinical trial of PTX-100 in patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL). Prescient ...
Trevi Therapeutics Reports Additional Analyses From Phase 2a RIVER Trial Of Haduvio May 20, 2025 — 07:59 am EDT Written by RTTNews.com for RTTNews -> ...
Phase 2A of the Harrison Avenue Streetscape Project in Panama City recently reopened pedestrian traffic from Four Points Plaza to 5th Street. The project aims to revitalize the downtown area with ...
Topas Therapeutics today announced that it will present clinical Phase 2a data on its lead candidate, TPM502, in celiac disease patients at the upcoming Digestive Disease Week ® (DDW) 2025, held ...
Bioxodes will now start preparing the launch of a potentially registrational Phase 2b trial of BIOX-101 in ICH. “While preliminary, the data from this study all point in the right direction. This ...
The route of Metro 3 Phase 2a spans 18.6 km, ... From street-side sizzles to 5-star restaurants, Mumbai’s flavour map is as diverse as its people. And now, it’s all just a metro ride away.
BASEL, Switzerland, March 26, 2025 /PRNewswire/ -- Vaximm AG, a subsidiary of OSR Holdings, Inc. and a pioneering biotechnology company focused on developing innovative immunotherapies, today ...
Following a Phase 1 clinical study that demonstrated an excellent safety profile with no significant adverse events in 72 healthy subjects, the company is moving forward with Phase 2a. This next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results